Diagnosed Prevalent Cases of Chronic Kidney Disease Set to Increase Globally

21st December 2017 (Last Updated December 21st, 2017 14:19)

The burden of chronic kidney disease (CKD) in the seven major markets (7MM: US, 5EU [France, Germany, Italy, Spain, UK], and Japan) is expected to grow between 2016 and 2026. GlobalData epidemiologists forecast an increase in the number of diagnosed prevalent cases of CKD, most notably in the 5EU and the US. Figure 1 presents the expected changes in the 7MM from 2016 to 2026.

Diagnosed Prevalent Cases of Chronic Kidney Disease Set to Increase Globally
Figure 1: 7MM, Diagnosed Prevalent Cases of CKD, Stages I–V, Both Sexes, Ages ≥20 Years, N, 2016 and 2026

CKD, also known as chronic renal disease, is an asymptomatic, long-term condition that damages the kidneys and leads to the loss of kidney function over time. As the disease progresses, the symptoms worsen, eventually leading to kidney failure. The glomerular filtration rate (GFR), a key measure of kidney function, is determined by the amount of creatinine in the blood, and the Kidney Disease, Improving Global Outcomes (KDIGO) classification system is considered the standard for GFR measurement and diagnosis of CKD.

In the 7MM, GlobalData epidemiologists forecast that the diagnosed prevalent cases of CKD, stages I–V, will grow by 9.9% over the forecast period, at an Annual Growth Rate (AGR) of 0.99%, from 25,777,808 cases in 2016 to 28,329,633 cases in 2026. In 2016, the US accounted for 21.56% of the diagnosed prevalent cases of CKD in the 7MM, with 5,557,199 cases. There were 17,187,838 cases in the 5EU, with 66.68% of the diagnosed prevalent cases. Japan had 3,032,771 cases, accounting for 11.77% of the diagnosed prevalent cases in the 7MM in 2016. Of the 7MM, the UK is expected to have the highest number of diagnosed prevalent cases, increasing from 13,397,021 in 2016 to 14,035,651 in 2026.

Details about the trend analysis and other discussions of CKD epidemiology can be found in the EpiCast Report: Chronic Kidney Disease – Epidemiology Forecast to 2026 and the EpiCast Model: Chronic Kidney Disease – Epidemiology Forecast to 2026.